| Company Name | Owkin Inc. (Waiv) |
| Founded | 2016 |
| Head office | Paris, France |
| Website | https://owkin.com |
| Contact |
Pathology products by Owkin Inc. (Waiv)
Subspeciality: Gastrointestinal pathology
Modality: Histopathology
Source: Public
Biomarker prediction
MSIntuit CRC is an AI digital pathology diagnostic solution that pre-screens for a biomarker in colorectal cancer tumors known as microsatellite instability (MSI) – a defect in a cell’s ability to correct mistakes that occur when DNA is copied. This diagnostic rules out microsatellite stable (MSS) phenotypes, allowing pathologists to concentrate their resources on confirming those patients who exhibit MSI.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
Risk stratification
RlapsRisk BC is an AI prognostic solution that predicts whether a breast cancer patient (ER+/HER2-) will go on to relapse after treatment, informing oncologists which high-risk patients may benefit from targeted therapies and which low-risk patients could potentially avoid chemotherapy.